VAQTA 50 [iU]/mL (hepatitis A vaccine, inactivated INJECTION, SUSPENSION) 50 [iU]/mL

VAQTA 50 [iU]/mL is an inactivated hepatitis A vaccine designed to prevent hepatitis A virus infection. This intramuscular injection is suitable for individuals seeking protection against hepatitis A.

Strength

50 [iU]/mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (0006-4841-00) / 1 mL in 1 VIAL, SINGLE-DOSE (0006-4841-01)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VAQTA 50 [iU]/mL is used to prevent hepatitis A, a viral liver disease. This vaccine is typically administered to individuals who are at risk of exposure to the hepatitis A virus, such as travelers to regions with high rates of hepatitis A or those in close contact with infected persons. The vaccine works by stimulating the body's immune response to develop protection against the virus.

Side Effects

Common effects of VAQTA 50 [iU]/mL may include soreness, redness, or swelling at the injection site. Some individuals may experience mild fever, headache, or fatigue following vaccination. These effects are usually temporary and resolve on their own.

Precautions & Warnings

VAQTA 50 [iU]/mL should be administered by a healthcare professional. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use. It is important to inform the healthcare provider about any current medications or health conditions before receiving the vaccine.

Avoid Interactions

VAQTA 50 [iU]/mL may interact with certain medications or other vaccines. It is advisable to discuss any current medications or recent vaccinations with a healthcare provider before receiving this vaccine. Alcohol and other immune-suppressing substances may affect the vaccine's effectiveness.

Frequently Asked Questions

VAQTA 50 [iU]/mL is used to prevent hepatitis A virus infection. It is typically administered to individuals at risk of exposure to the virus.

VAQTA 50 [iU]/mL is administered as an intramuscular injection by a healthcare professional.

Common side effects may include soreness, redness, or swelling at the injection site, as well as mild fever, headache, or fatigue.

Individuals with a history of severe allergic reactions to any component of the vaccine should avoid its use.

It is important to discuss any current medications with a healthcare provider before receiving VAQTA 50 [iU]/mL to avoid potential interactions.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.